Published 11 days ago • loading... • Updated 10 days ago

Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease

A new study suggests Type 2 diabetes medications may lower Alzheimer's risk.
Diabetes is a known risk factor, making glucose-lowering drugs relevant for study.
Researchers, including those at the University of Florida, analyzed Medicare data and clinical trials.
The data showed statistically significant risk reductions with GLP-1RAs and SGLT2is use.
The findings suggest potential neuroprotective effects, warranting studies in broader populations.

Insights by Ground AI

Does this summary seem wrong?

11 Articles

All

Left

Center

Right

PR Newswire

Center

DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a new strategic...

10 days ago·United States

Read Full Article

Science Daily

Center

Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease

Drugs like Ozempic, other blood sugar-reducing medications, may stave off dementia.

11 days ago·United States

Read Full Article

Science Alert

Center

Weight-Loss Drugs Like Ozempic May Guard Against Dementia, Research Finds

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and protection from dementia may soon be added to the list.

11 days ago·Australia

Read Full Article